CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Operating expenses:
Research and development	$ 5,335,500	$ 1,601,800	$ 13,340,300	$ 5,124,600
General and administrative	1,856,800	1,266,000	5,494,100	4,997,400
Total operating expenses	7,192,300	2,867,800	18,834,400	10,122,000
Loss from operations	(7,192,300)	(2,867,800)	(18,834,400)	(10,122,000)
Other expenses, net:
Interest expense, net	(1,800)	(2,000)	(6,800)	(7,700)
Loss on extinguishment of accounts payable	(22,700)	(135,000)	(22,700)	(135,000)
Loss before income taxes	(7,216,800)	(3,004,800)	(18,863,900)	(10,264,700)
Income taxes	0	0	(2,400)	(2,400)
Net loss and comprehensive loss	(7,216,800)	(3,004,800)	(18,866,300)	(10,267,100)
Accrued dividends on Series B Preferred stock	(290,900)	(263,000)	(848,000)	(766,600)
Deemed dividend from trigger of down round provision feature	0	(199,200)	0	(199,200)
Net loss attributable to common stockholders	$ (7,507,700)	$ (3,467,000)	$ (19,714,300)	$ (11,232,900)
Basic and diluted net loss attributable to common stockholders per common share	$ (0.24)	$ (0.25)	$ (0.75)	$ (1.03)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share	30,696,312	13,895,642	26,418,440	10,947,556